نتایج جستجو برای: mf59

تعداد نتایج: 256  

2013
Wan-Ting Huang Hsu-Wen Yang Tzu-Lin Liao Wan-Jen Wu Shu-Er Yang Yi-Chien Chih Jen-Hsiang Chuang

In Taiwan, new H1N1 monovalent vaccines without adjuvant and with MF59® adjuvant were used in the nationwide vaccination campaign beginning on November 1, 2009. From November 2009 through February 2010, the authors identified recipients of H1N1 vaccines who were diagnosed with adverse events of special interest (AESIs) in a large-linked safety database, and used the self-controlled case series ...

Journal: :European journal of internal medicine 2010
Giuseppe Lippi Giovanni Targher Massimo Franchini

Squalene, a hydrocarbon obtained for commercial purposes primarily from shark liver oil and other botanic sources, is increasingly used as an immunologic adjuvant in several vaccines, including seasonal and the novel influenza A (H1N1) 2009 pandemic flu vaccines. Nearly a decade ago, squalene was supposed to be the experimental anthrax vaccine ingredient that caused the onset of Persian Gulf Wa...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2009
Grazia Galli Duccio Medini Erica Borgogni Luisanna Zedda Monia Bardelli Carmine Malzone Sandra Nuti Simona Tavarini Chiara Sammicheli Anne K Hilbert Volker Brauer Angelika Banzhoff Rino Rappuoli Giuseppe Del Giudice Flora Castellino

Immune responses to vaccination are tested in clinical trials. This process usually requires years especially when immune memory and persistence are analyzed. Markers able to quickly predict the immune response would be very useful, particularly when dealing with emerging diseases that require a rapid response, such as avian influenza. To address this question we vaccinated healthy adults at da...

Journal: :Journal of preventive medicine and hygiene 2011
S Iannazzo

INTRODUCTION Influenza vaccination has proven effective in the reduction of influenza-like illness (ILI) cases and influenza-related hospitalizations, drug consumption, primary care consultations and deaths in the elderly population. The aim of this study is the assessment of the financial budget impact of a seasonal vaccination program based on the use of the MF59 adjuvanted vaccine as compare...

Journal: :Journal of the National Cancer Institute 2001
C D Harro Y Y Pang R B Roden A Hildesheim Z Wang M J Reynolds T C Mast R Robinson B R Murphy R A Karron J Dillner J T Schiller D R Lowy

BACKGROUND Studies in animal models have shown that systemic immunization with a papillomavirus virus-like particle (VLP) vaccine composed of L1, a major structural viral protein, can confer protection against subsequent experimental challenge with the homologous virus. Here we report results of a double-blind, placebo-controlled, dose-escalation trial to evaluate the safety and immunogenicity ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید